Author

R. K. Soni

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Hernandez-Ono· 1 shared A. Iavarone· 1 shared A. J. Dannenberg· 1 shared A. Lasorella· 1 shared A. Rosenberg· 1 shared B. Desai· 1 shared C. Lacefield· 1 shared C. Xue· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

A. Hernandez-Ono

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Adipocyte Tribbles1 Regulates Plasma Adiponectin and Plasma Lipids in Mice

E. E. Ha, G. I. Quartuccia, R. Ling, C. Xue, A. Hernandez-Ono, R. Imam, J. Cui, R. K. Soni, R. C. Bauer

This study shows that adipocyte Trib1 regulates plasma adiponectin, cholesterol, and triglycerides in mice, confirming human genetic associations and revealing a novel mechanism for Trib1's role in lipid metabolism.

bioRxiv · Mar 11, 2021 · PreprintPhysiology

Quantitative Mapping of Human Hair Graying and Reversal in Relation to Life Stress

A. Rosenberg, S. Rausser, J. Ren, E. Mosharov, G. M. Sturm, R. T. Ogden, P. Patel, R. K. Soni, C. Lacefield, D. J. Tobin, R. Paus, M. Picard

This study quantifies hair graying and its reversal in humans, linking it to stress and showing proteomic and computational evidence of reversibility.

bioRxiv · May 18, 2020Cell Biology

Anti-tumor effects of an Id antagonist with no acquired resistance

P. M. Wojnarowicz, M. G. Escalono, Y.-H. Huang, B. Desai, Y. Chin, R. Shah, S. Xu, O. Ouerfelli, R. K. Soni, J. Philip, D. C. Montrose, J. H. Healey, V. K. Rajasekhar, W. A. Garland, L. Norton, , R. Benezra

This study demonstrates that AGX51, an Id antagonist, effectively inhibits tumor growth in multiple cancer models without inducing acquired resistance.

bioRxiv · Jan 6, 2020 · PreprintCancer Biology